Pharmaceutical Executive: What gaps continue to exist in GLP-1 coverage in the employer benefits market? Susan Thomas: Most employers think of GLP-1 coverage in two buckets: one for type 2 diabetes and the other for weight loss. PE: What is the business case for employer-based GLP-1 coverage? PE: Why is GLP-1 coverage important for menopause? Thomas: Women in that age range are disproportionately impacted by cardiovascular risk because of the metabolic changes that occur during perimenopause and menopause.